McNeil Consumer & Specialty Pharmaceuticals launches $30M campaign

Johnson & Johnson's McNeil Consumer & Specialty Pharmaceuticals launched a $30 million campaign for chewable Tylenol, targeting a younger-than-usual audience: 30- and 40-somethings with kids. The TV, print and poster ads, created by Deutsch, aim to capture the 30% of households where families fail to take headache remedies for reasons of inconvenience, according to Advertising Age.
You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical


Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.